Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling AxisThe hepatic SLC13A5/SLC25A1-ATP鈥揹ependent citrate lyase (ACLY) signaling pathway, responsible for maintaining the citrate homeostasis, plays a crucial role ...
A therapeutic cooperation by bempedoic acid and proprotein convertase subtilisin/kexin type 9 inhibitors in statin intolerance inherited dyslipidemiasdoi:10.1007/s11739-024-03674-9Francesco Sbranahttps://ror.org/058a2pj71grid.452599.60000 0004 1781 8976U.O. Lipoapheresis and Center for Inherited ...
Bempedoic acid faces the complex scenario of dyslipidemia with an intriguing pharmacological potential that could make it an interesting alternative in the management of LDL-C-related atherosclerotic diseases. In the present work, its biochemical properties and therapeutic potential mainly vs. statins will...
Bempedoic acid faces the complex scenario of dyslipidemia with an intriguing pharmacological potential that could make it an interesting alternative in the management of LDL-C-related atherosclerotic diseases. In the present work, its biochemical properties and therapeutic potential mainly vs. statins will...